8th Annual Spring to Life

CONFERENCE ON LEUKEMIAS 2021

May 14-15, 2021

Proudly Hosted by New York Oncology Hematology, PC

PROUDLY HOSTED BY:

EVENT INFORMATION

This is a CME-Accredited Online LIVE Broadcast
Upon registration, confirmation will be provided via email
Login information and instructions will be emailed to you prior to the event

Next quote »

"Identification of molecular drivers has resulted in tailored treatments for our patients with non-small cell lung cancer which are not only more effective, but less toxic. It is essential the community oncologist have a keen knowledge of the most current precision testing techniques and incorporate newer therapies to provide state-of-the-art care to patients close to home."

-Makenzi Evangelist, M.D., New York Oncology Hematology

“The landscape of lung cancer with new biomarkers, immunotherapies, and targeted therapies is constantly evolving, and it is a challenge for the community oncologist to integrate and apply this new knowledge in daily clinical practice. Accessible continuing education forums are crucial to support this rapid evolution of cancer care."

-Nischala Ammannagari, M.D., New York Oncology Hematology

Registration

Please click here if you would like to be notified when registration is open. We hope to see you in 2020!

S2L | Registration HCP

First Name *

Last Name

Title Title

Specialty

Institution *

Street Address *

Additional Address

City *

State/Province *

ZIP/Postal *

Country *

Confirm Email

Phone

How did you hear about the conference? * How did you hear about the conference?

reCAPTCHA

PROGRAM OVERVIEW

The focus of the 10^th Annual Spring to Life Conference is Aggressive Lymphomas. The purpose of this conference is to educate practitioners and update their knowledge of the biological pathways, diagnosis, current guidelines, and the existing and emerging therapies for the management of patients with Lymphoma.

TARGET AUDIENCE

The target audience for this conference is the medical oncologist, hematologists, pathologists, oncology nurses, advanced practice providers, family practitioners, primary care practitioners, allied health professionals, and other providers with an interest in the care of patients with lymphoma.

LEARNING OBJECTIVES

After participating in this activity, learners will be better able to:

Understand the current classification system of the lymphoma
Discuss updated data on novel agents and therapeutic approaches for patients with aggressive lymphoma.
Discuss current standard of care approach in patient with newly diagnosed and relapsed refractory aggressive B cell lymphoma and T cell lymphoma.
Understand the diagnostic and management approaches in patient with uncommon presentation of lymphoma and CNS lymphoma.
Understand the disease process and treatment strategies in patients with Hodgkin Lymphoma.
Identify the unmet need and upcoming strategies in elderly patients with lymphoma.
Understand the complex diagnosis paradigm and management of thrombotic microangiopathies

PLANNING COMMITTEE and Co-Chairs/Moderators

Ira Zackon, MD
New York Oncology Hematology,
Immediate Past President
Hematologist/Medical Oncologist
NYOH Albany Medical Center
Clinical Assistant Professor
Albany Medical College
Albany, NY

Mihir Raval, MD, MPH
Hematology and Stem cell transplant
New York Oncology and Hematology,
Clinical Assistant Professor
Transfusion Committee Chair
Albany Medical College
Albany, NY/p>

Faculty

Mahmoud Aldyab, MD
Pathology Residency
Albany Medical Center
Albany, NY

Jennifer Crombie, MD
Assistant Professor of Medicine
Dana-Farber Cancer Institute
Boston, MA

Reju George, MD
Hematologist-Oncologist
New York Oncology Hematology
Albany, NY

Steven Horwitz, MD
Medical Oncologist
Member and Attending Physician
Memorial Sloan Kettering Cancer Center
New York, NY

Austin Kim, MD
Instructor of Medicine
Harvard Medical School
Dana-Farber Cancer Institute
Boston, MA

Jeffrey Laurence, MD
Professor of Medicine
Weill Cornell Medicine
New York, NY

Kah Poh (Melissa) Loh, MBBCh BAO, MS
Assistant Professor
University of Rochester Medical Center
Rochester, NY

Reid W. Merryman, MD
Assistant Professor
Dana-Farber Cancer Institute
Boston, MA

Alison Moskowitz, MD
Associate Attending
Memorial Sloan Kettering Cancer Center
New York, NY

Tipu Nazeer, MD
Professor and Program Director
Director, Hematopathology
Albany Medical Center
Albany, NY

Patrick Reagan, MD
Associate Professor
Wilmot Cancer Institute
Rochester, NY

Susan Weaver, MD
Assistant Professor
Albany Medical Center
New York Oncology Hematology
Albany, NY

Qin Zen, MD, PhD
Attending Physician
New York Oncology Hematology
Albany, NY

Faculty Documentation

Thank you for agreeing to participate in the conference!

Please click on the link below to submit your faculty documentation.

Email Nicole Falco if you have any questions: [email protected]

Submit faculty documentation

Faculty

Ghassan Abou-Alfa, MD, MBA
Professor
Memorial Sloan Kettering Cancer Center
New York, NY

Lindy Davis, MD, FACS
Assistant Professor of Surgery
Albany Medical Center
Albany, NY

David H. Ilson, MD PhD
Attending Physician
Gastrointestinal Oncology Service
Division of Solid Tumor Oncology
Department of Medicine
Memorial Sloan Kettering Cancer Center
Professor of Medicine
Weill Cornell Medical College
New York, NY

Rebecca Keim, MD, FACS
Hepato-Pancreatic-Biliary Surgeon
St. Peter's Health Partners Medical Associates
Albany, NY

Jeffrey Meyerhardt, MD, MPH, FASCO
Chief Clinical Research Officer
Professor of Medicine
Dana-Farber Cancer Institute
Boston, MA

Eileen M. O’Reilly, MD
Winthrop Rockefeller Endowed Chair in Medical Oncology
Section Head, Hepatopancreaticobiliary & Neuroendocrine Cancers
Co-Director Medical Initiatives, David M. Rubenstein Center for Pancreatic Cancer
Chair, Institutional Review Board
Attending Physician, Member, Memorial Sloan Kettering Cancer Center
Professor of Medicine, Weill Cornell Medical College
New York, NY

Mitchell C. Posner M.D., FACS
Thomas D. Jones Professor of Surgery and Vice-Chairman
Chief, Section of General Surgery
and Surgical Oncology
Physician-in-Chief, UCM Comprehensive Cancer Center
Professor, Radiation and Cellular Oncology
University of Chicago Medicine
Chicago, IL

Benjamin L. Schlechter, MD
Instructor
Harvard Medical School
Attending Physician
Gastrointestinal Cancer Center
Dana Farber Cancer Institute
Boston, MA

Christopher Stark, MD
Assistant Professor of Radiology
Vascular and Interventional Radiology
Albany Medical College

Jonathan Strosberg, MD
Professor
Moffitt Cancer Center
Tampa, FL

The 10th Annual Spring to Life: Conference on Aggressive Lymphomas is going to be held live in-person at The Saratoga Hilton. The conference will be recorded and will be offered on-demand 60-90 days following the conference.

DOWNLOAD AGENDA

DOWNLOAD SUPPORT OPPORTUNITIES

ONLINE EXHIBIT APPLICATION

Conference Organizers Contact Information:

1-800-973-0665
[email protected]

To view previous years' programs, collaborators, educational grant providers, sponsors and exhibitors, please click here.

Host

The 10th Annual Spring to Life: Conference on Aggressive Lymphomas is proudly hosted by:

ACCREDITATION Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Medical Society of the State of New York (MSSNY) and myMedEd, Inc. MSSNY is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation Statement

The Medical Society of the State of New York designates this live activity for a maximum of 8.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ASSURANCE AOF BALANCED, UNBIASED, AND FAIR CONTENT: As an ACCME-accredited provider, MSSNY must identify and mitigate relevant financial relationships of all individuals controlling CME content.

Financial relationships are relevant if the following three conditions are met for the prospective person who will control the content of the education:

A financial relationship, in any amount, exists between the person in control of content and an ineligible company.
The financial relationship existed during the past 24 months
The educational content is related to the products of an ineligible company with whom the person has a financial relationship.

Mechanisms to ensure that presentations are free from commercial bias are in place. Faculty will also disclose any off-label and/or investigational use of pharmaceuticals or instruments discussed in their presentation.

The mission of Spring to Life™ is to reflect and transmit all that is evolving in the whole of the field of oncology. The annual conference continues to bring together faculty speakers that reflect local, regional and national expertise in the field. This collaboration of community-based oncologists with academic leaders highlights the impact of the research that advances our understanding and ultimately impacts the lives of our patients whom we serve.

Click on the links below to view the programs from years past.

2014 The Acute Leukemias - AML and ALL

2015 Aggresive B-Cell Non-Hodgkin Lymphomas

2016 Plasma Cell Diseases

2017 Myeloproliferative Neoplasms (MPNs)

2018 Incident Lymphoid Malignancies

2019 Harnessing the Power of our Immune System in Cancer Therapy

2020 Lung Cancer

2021 Leukemias

2022 Gastrointestinal Cancers

2023 Aggressive Lymphomas

Thank you to the collaborators, educational grant providers, sponsors and exhibitors, past and present, who have made this event possible: